Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Small Lymphocytic Lymphoma
Related studies linked through entity extraction aliases.
Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
- Status
- RECRUITING
- Phase
- PHASE2
Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Cardiotoxicities in Patients Receiving BTKi
- Status
- WITHDRAWN
- Phase
- N/A
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Anti-pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:
- Status
- RECRUITING
- Phase
- N/A
Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With Venetoclax
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Zanubrutinib Followed Zanubrutinib Plus FCR / BR in Newly Diagnosed Symptomatic CLL/SLL
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Status
- RECRUITING
- Phase
- PHASE3
Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial
- Status
- RECRUITING
- Phase
- PHASE2
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE2
PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2